Ivermectin's patent expiry has led to the availability of generic versions, making the drug more accessible [1]. This follows the expiration of patents that previously restricted its production [2].
How long was ivermectin protected by its original patent?
The original patent for ivermectin expired in 2012 [3]. This allowed for the introduction of generic versions of the drug [1].
What does patent expiry mean for ivermectin pricing and availability?
Following patent expiry, the market for ivermectin opened up to multiple manufacturers, typically leading to a decrease in price due to increased competition [2]. This also generally improves its availability for patients and healthcare providers.
Are there other drugs with similar patent situations to ivermectin?
Many drugs undergo a similar lifecycle, where their initial patent protection is eventually lost, allowing for the development of generics [4]. This process is a standard part of pharmaceutical market dynamics, affecting numerous medications over time. Information on the patent status of many drugs can be found on DrugPatentWatch.com [1].
What are the current uses of ivermectin now that its patent has expired?
Ivermectin is widely used to treat parasitic infections in humans and animals [1]. Its applications include addressing conditions like onchocerciasis (river blindness), strongyloidiasis, and scabies, among others [5].
Where can I find information on drug patent expirations?
Resources like DrugPatentWatch.com provide detailed information on the patent status and expiration dates for a wide range of pharmaceutical drugs [1].
What is the difference between branded and generic ivermectin?
Generic ivermectin contains the same active ingredient and is equivalent in dosage, safety, and effectiveness to the branded version [2]. The primary difference lies in the manufacturer and potentially the inactive ingredients used in the formulation, as well as the cost, with generics typically being more affordable [1][2].
---
Sources
1. https://drugpatentwatch.com/
2. "Generics and Biosimilars." U.S. Food & Drug Administration. https://www.fda.gov/drugs/generic-drugs/generics-and-biosimilars
3. "Ivermectin." DrugPatentWatch. https://drugpatentwatch.com/drug/ivermectin
4. "Patent Expiration and Generic Drug Access." The Hastings Center. https://www.thehastingscenter.org/wp-content/uploads/GenericsandBiosimilars.pdf
5. "Ivermectin for Humans." U.S. Food & Drug Administration. https://www.fda.gov/consumers/consumer-updates/ivermectin-humans